Dealert› Deals› Tasmanian Botanics

Yongji Health → Tasmanian Botanics

Buyout Australia Alternative Medicine Family-Owned / Founder(s) / Entrepreneur(s) / Private Individual(s)
Deal summary

Information on the target

Tasmanian Botanics, located in Pontville, Tasmania, is one of Australia's largest cultivators of medicinal cannabis. The company operates a comprehensive cannabis farm and processing facility, which includes a greenhouse and an outdoor crop spanning approximately 2.5 hectares. Tasmanian Botanics is dedicated to the cultivation, manufacturing, and packaging of high-quality medicinal cannabis products, catering to the growing demand in the Australian market.

Recently, Tasmanian Botanics has come under the ownership of Yongji Health, a subsidiary of a Guizhou-based company. This acquisition marks a significant shift in the ownership structure, with Yongji now holding over 95 percent of the shares in Tasmanian Botanics. The deal, valued at approximately $31 million, underscores the increasing interest and investment in the Australian medicinal cannabis sector.

Industry overview in the target’s specific country

The alternative medicine industry in Australia, particularly in the realm of medicinal cannabis, has experienced substantial growth in recent years. Following the legalization of medicinal cannabis in 2016, the sector has seen a surge in demand, with over a million prescriptions written since its inception. This rapid expansion has positioned Australia as a key player in the global alternative medicine landscape.

Despite the promising growth, the Australian medicinal cannabis industry faces significant challenges, particularly from international competitors. Countries like Thailand have emerged as formidable players, offering lower production costs and a more established market presence. This influx of foreign competition has prompted Australian producers to innovate and enhance their operational efficiencies to maintain market share.

Moreover, regulatory frameworks in Australia continue to evolve, impacting the operational landscape for companies within the alternative medicine sector. The Australian government has been working to streamline licensing processes and improve access to medicinal cannabis products, which is crucial for sustaining industry growth. As the market matures, companies are increasingly focusing on quality, compliance, and consumer education to differentiate themselves in a crowded marketplace.

In this context, Tasmanian Botanics stands out as a significant contributor to the local industry, leveraging its established operations and expertise to navigate the competitive…

This is a public preview. The full deal page — disclosed financials, full description, advisers, comparable set — is available with a free account.
Create free account
View primary source ↗